An Evaluation of the Safety and Efficacy of the Administration of a Fixed Combination of Moxifloxacin 0.5% and Dexamethasone 0.1% Eye Drops Compared With the Individual Administration of Moxifloxacin 0.5% and Dexamethasone 0.1% in the Treatment of Bacterial Ocular Inflammation and Infection (Blepharitis and/or Keratitis and/or Conjunctivitis) (BRA-07-02)

NCT00732446 Phase 3 COMPLETED

Safety and efficacy of antibiotic steroid combination compared with individual administration in the treatment of bacterial ocular inflammation and infection (blepharitis and/or keratitis and/or conjunctivitis).

Details

Lead sponsor	Federal University of São Paulo
Phase	Phase 3
Status	COMPLETED
Enrolment	100
Start date	2008-08
Completion	2009-02

Conditions

• Blepharitis
• Conjunctivitis
• Keratitis

Interventions

• Moxifloxacin and Dexamethasone combined
• Moxifloxacin
• Dexamethasone

Primary outcomes

• Evaluation of ocular sign/symptoms (hyperemia on bulbar conjunctiva, palpebral conjunctiva, conjunctival exsudates, palpebral erythema at final visit (Day 8) — Day 8

Countries

Brazil